Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Lloyds TSB Group plc to implement ORTEC's ALM Software.
- M2 PRESSWIRE-7 November 2006-ORTEC: Lloyds TSB Group plc to implement ORTEC's ALM SoftwareC1994-2006 M2 COMMUNICATIONS LTD RDATE:07112006 Lloyds TSB Group plc LTSB has successfully implemented the Asset Liability Management software for Pension Funds PALM from ORTEC. The software enables the Group...
- Research articles 2006-11-07
Additional Resources
- FDA Approves Ortec's Protocol and Initiation Of Confirmatory Trial of OrCel® for Venous Ulcers
- NEW YORK -- Ortec International, Inc. ORTN announced today that it has received formal notification from the Food and Drug Administration FDA that it has approved Ortec's clinical study design and protocol and authorized Ortec to initiate the confirmatory study to support the safety and effectiveness results contained in Ortec's...
- Research articles 2005-07-19
- Ortec Successfuly Defends European Patent On Orcel
- Ortec International (Nasdaq:ORTC), New York, has successfully defended an opposition filed with the European Patent Office by Advanced Tissue Sciences, Inc. challenging the validity of Ortec's European patent on OrCelTM, Ortec's tissue engineering platform technology. Commenting on the successful defense, Steven Katz, Ph.D., Ortec's chairman and CEO stated, "This...
- Research articles 2002-05-01
- Visual Mining's NetCharts and NetCharts Pro Provides Graphics for ORTEC's Asset Liability Management Applications
- ROCKVILLE, Md. -- Visual Mining, Inc., a leading developer of reporting and data visualization solutions, today announced that Netherlands-based ORTEC has selected NetChartsR and NetChartsR Pro to generate dynamic interactive charts in products like OPAL, ORTEC's suite of personal asset liability management applications. Most of ORTEC's clients are in the...
- Research articles 2004-07-13
- The Ortec business unit of Ametek, Inc. (Oakridge, TN, www.ortec-online.com), will commercialized Lawrence Livermore National Laboratory's RadScout radiation detection technology.(Agreements and Aquisitions, Etc.)(Brief Article)
- The Ortec business unit of Ametek, Inc. (Oakridge, TN, www.ortec-online.com), will commercialize Lawrence Livermore National Laboratory's RadScout radiation detection technology. Ortec will incorporate the technology into its next generation of portable nuclear detection systems. The systems will be used at border crossings, cargo ship docks,...
- Research articles 2003-09-01
- Dawson-Samberg Entities to Increase Ownership Stake in Ortec International; Ortec Announces Extension of Expiration Date of Class B Warrants
- NEW YORK--BUSINESS WIRE--Dec. 3, 1998--Ortec International Inc. (NASDAQ: Small Cap: ORTC) announced today that Dawson-Samberg Capital Management and its related entities have entered into a definitive agreement to increase its percentage holding in Ortec to 12.2% of outstanding shares. Under the terms of the private placement, Dawson-Samberg will invest...
- Research articles 1998-12-03
- Ortec International Corrects Subhead and Boilerplate
- Business Editors CORRECTION...by Ortec International --BUSINESS WIRE In BW 2282, (NY-ORTEC-INTERNATIONAL), Ortec's Tissue Engineered Product to be Marketed Under Trade Name of OrCel, the subhead should read xxx Burn Victims sted xxx Burn Patients. Also, in the boilerplate, 10th-11th line, the sentence "Ortec submitted the PMA...
- Research articles 2001-07-16
- Ortec Successfully Defends European Patent on its OrCel Technology
- Business Editors & Health/Medical Writers BIOWIRE2K NEW YORK--BW HealthWire--March 25, 2002 Ortec International (Nasdaq:ORTC) today announced that it has successfully defended an opposition filed with the European Patent Office by Advanced Tissue Sciences, Inc. challenging the validity of Ortec's European patent on OrCelTM, Ortec's tissue engineering platform...
- Research articles 2002-03-25
- Ortec To Trade on Bulletin Board
- Business Editors & Health/Medical Writers BIOWIRE2K NEW YORK--BUSINESS WIRE--Aug. 30, 2002 Ortec International, Inc. announced today that NASDAQ has denied Ortec's appeal for continued inclusion on the NASDAQ Small CAP Market. Ortec was advised last evening after the close of the Market, that effective with the open...
- Research articles 2002-08-30
- Ortec Set to Initiate 60 Patient Confirmatory Trial For Venous Leg Ulcer Approval; Final Version of Study Protocol and Clinical Design Submitted to FDA
- NEW YORK -- Ortec International, Inc. ORTN announced today that it has come to an agreement with the Food and Drug Administration FDA on the parameters of a 60 patient confirmatory trial evaluating OrCelR in the treatment of venous ulcers and has submitted a final version of the study protocol...
- Research articles 2005-06-28
- FDA Completes Review of Ortec's Diabetic Foot Ulcer Protocol And Gives Clearance to Initiate Diabetic Foot Ulcer Trial
- NEW YORK -- Ortec International, Inc. ORTN today announced that the Food and Drug Administration FDA has completed a review of the modified Diabetic Foot Ulcer DFU Protocol submitted to the FDA on January 6, 2005 and has given Ortec permission to initiate a pivotal trial evaluating OrCelR in the...
- Research articles 2005-02-09
- Ortec International in private placement
- NEW YORK--BUSINESS WIRE--Oct. 23, 1996--Ortec International Inc. (NASDAQ:ORTC) announced today the sale of 332,100 shares of its common stock in a private placement at an average price of $6.53 per share, which was 80% of the average closing prices for Ortec's shares for the five day periods immediately before the...
- Research articles 1996-10-23
- Ortec to Receive Widening Protection of Its Platform Technology; Patent Will Extend Platform to Soft, Connective, Muscle and Neural Tissues
- NEW YORK--BUSINESS WIRE--March 10, 1999--Ortec International, Inc. (Nasdaq:ORTC) has received a Notice of Allowance from the U.S. Patent Office allowing the claims of an additional patent application on its platform technology. The new claims when issued will extend Ortec's protection to the use of its structure in conjunction with...
- Research articles 1999-03-10
- Ortec Files PMA for OrCel(R) for VLU Indication
- Ortec International, Inc. (OTCBB: OTCI), a company focused on advancing regenerative medicine through the development of cellular technology and advanced biomaterial products, announced today that it has filed the final safety and efficacy data required by the Food and Drug Administration FDA to evaluate its Pre-Market Approval PMA application for...
- Research articles 2007-10-23
- Ortec Provides FDA Update
- NEW YORK -- Ortec International, Inc. ORTN announced that it has been informed by the Food and Drug Administration FDA that it has received from Ortec all the information required for the FDA to complete its review and arrive at its recommendation for our Pre-Market Approval PMA application for the...
- Research articles 2005-04-14
- Ortec and Center for Tissue Engineering at University of California at Berkeley to Collaborate on Cardiovascular Tissue Regeneration
- NEW YORK -- Ortec International, Inc. ORTN announced today initiation of a collaboration with Dr. Song Li, at the Center for Tissue Engineering of the University of California at Berkeley (http://ctelab.berkeley.edu/research.htm), to evaluate the potential of Ortec's proprietary collagen scaffold for application to cardiovascular tissue regeneration. The initial research will...
- Research articles 2005-05-19
- Ortec to be Granted Fourth Patent
- Business Editors & Health/Medical Writers BIOWIRE2K Ortec International, Inc. (NASDAQ:ORTC) announced today that it has received notification from the U.S. Patent Office that the Company's claims covering unique manufacturing processes for its tissue engineered product, OrcelTM, have been granted. These processes specifically relate to the manufacturing of...
- Research articles 2002-07-03
- Ortec Granted Fourth Patent
- Business Editors & Health/Medical Writers BIOWIRE2K NEW YORK--BUSINESS WIRE--Jan. 30, 2003 Ortec International, Inc. (ORTC.OB) announced today that the U.S. Patent Office has issued a patent covering unique manufacturing processes for its tissue engineered product, OrCelR. These processes specifically relate to the manufacturing of Ortec's bilayered...
- Research articles 2003-01-30
- Price and Volume Alerts for Tuesday August 22, 2006 - Featuring North Star Diamonds, Open Energy, Old Harbor Bank, Ortec International, and More.
- M2 PRESSWIRE-22 August 2006-Stockguru.com: Price and Volume Alerts for Tuesday August 22, 2006 - Featuring North Star Diamonds, Open Energy, Old Harbor Bank, Ortec International, and MoreC1994-2006 M2 COMMUNICATIONS LTD RDATE:22082006 Dallas, Texas - StockGuru Price and Volume Alerts for Tuesday...
- Research articles 2006-08-22
- StockGuru Price and Volume Alerts for Tuesday May 30, 2006 - Ortec CEO Details Corporate Vision while American Energy Production Inc. Announces ``It Rained''.
- M2 PRESSWIRE-30 May 2006-Stockguru.com: StockGuru Price and Volume Alerts for Tuesday May 30, 2006 - Ortec CEO Details Corporate Vision while American Energy Production Inc. Announces ``It Rained''C1994-2006 M2 COMMUNICATIONS LTD RDATE:30052006 Dallas, Texas - StockGuru Price and Volume Alerts for...
- Research articles 2006-05-30
- << Previous
- page 1 of 1
- Next >>
